NG2-73 |
ADIPIPLON |
APIPLON |
FDA Approval | not approved |
Drug Class | Small molecule |
Drug Indications | hypnotic |
n/a |
Trial Name | NG2-73 |
Novel drug target | Established target |
n/a |
Trial Name | NG2-73 |
Novel drug target | Established target |
partial agonist (activating) |
Mechanism of Interaction | GABA-A receptor; benzodiazepine site partial agonist |
Direct Interaction | yes |
Trial Name | NG2-73 |
n/a |
Trial Name | NG2-73 |
Novel drug target | Established target |
partial agonist (activating) |
Mechanism of Interaction | GABA-A receptor; benzodiazepine site partial agonist |
Direct Interaction | yes |
Trial Name | NG2-73 |
partial agonist (activating) |
Direct Interaction | yes |
Mechanism of Interaction | GABA-A receptor; benzodiazepine site partial agonist |
Trial Name | NG2-73 |
partial agonist (activating) |
Novel drug target | Established target |
Trial Name | NG2-73 |
Mechanism of Interaction | GABA-A receptor; benzodiazepine site partial agonist |
partial agonist (activating) |
Mechanism of Interaction | GABA-A receptor; benzodiazepine site partial agonist |
Direct Interaction | yes |
Trial Name | NG2-73 |
partial agonist (activating) |
Mechanism of Interaction | GABA-A receptor; benzodiazepine site partial agonist |
Direct Interaction | yes |
Trial Name | NG2-73 |
partial agonist (activating) |
Novel drug target | Established target |
Trial Name | NG2-73 |
Mechanism of Interaction | GABA-A receptor; benzodiazepine site partial agonist |
partial agonist (activating) |
Trial Name | NG2-73 |
Novel drug target | Established target |
Direct Interaction | yes |
n/a |
Novel drug target | Established target |
Trial Name | NG2-73 |
n/a |
Trial Name | NG2-73 |
Novel drug target | Established target |
n/a |
Novel drug target | Established target |
Trial Name | NG2-73 |
n/a |
Trial Name | NG2-73 |
Novel drug target | Established target |
n/a |
Trial Name | NG2-73 |
Novel drug target | Established target |
n/a |
Trial Name | NG2-73 |
Novel drug target | Established target |
partial agonist (activating) |
Mechanism of Interaction | GABA-A receptor; benzodiazepine site partial agonist |
Direct Interaction | yes |
n/a |
Trial Name | NG2-73 |
Novel drug target | Established target |
Drug Indications | hypnotic |
Drug Class | Small molecule |
FDA Approval | not approved |
D0B9OG | TTD Drug ID |